IP Verse

Low Frequency Glatiramer Acetate Therapy - EP2630962B1

PatentPatent Analysis

EP2630962

YEDA RESEARCH
Application Number
EP13166080A
Filing Date
Aug 19, 2010
Status
Revoked
May 10, 2024
Grant Date
Jun 27, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3793447B1
EP2566954B2
EP3097923B1

Bibliography

The patent EP2630962B1 was granted to Yeda Research on Jun 27, 2018 following the initial filing on Aug 19, 2010 under the application number EP13166080A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ALVOGEN IPCOMar 27, 2019ADMISSIBLE
HEXALMar 27, 2019WITHDRAWN
G L PHARMAMar 26, 2019ADMISSIBLE
SYNTHONMar 26, 2019ADMISSIBLE
GENERICS UK TRADING MYLANMar 25, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents